US

Autolus scores $80 mln Series C

London-based Autolus, a biopharmaceutical company focused on developing and commercializing T-cell therapies, has raised $80 million in Series C funding. The investors included Arix Bioscience plc, Cormorant Asset Management, Nextech Invest, Syncona and Woodford Investment Management.

Millennial women's health platform Tia grabs $2.5 mln seed

San Francisco-based Tia, a women's health platform for millennial women, has secured $2.5 million in seed financing. The investors were Combine, Homebrew and Compound.

Partners for Growth raises $276 mln for fifth fund

Partners for Growth has closed its fifth fund at $276 million. PFG focuses on financing growth businesses in the tech and life sciences sectors.

CallRail nabs $75 mln

CallRail, a call analytics platform, has closed $75 million in funding. The investors were Sageview Capital and Leaders Fund. In addition to the funding, Dean Nelson, a partner at Sageview and Steve DeBacco from Leaders Fund have joined CallRail's board of directors.

Integra Holdings inks $25 mln

Integra Holdings, an investment company exclusively focused on life science innovations originating from the Hebrew University, has raised $25 million in funding. Temasek led the round with participation from Arie Capital and The Israeli Teachers' and Kindergarten's Study Funds.

VC-backed T-Rex taps Miller as chief business development officer

New York City and Israel-based T-Rex, a provider of data, risk and valuation analysis and structuring tools for esoteric asset classes, has appointed Scott G. Miller as chief business development officer. Previously, Miller worked at FactSet Research Systems where he was executive vice president and global director. T-Rex is backed by Safeguard Scientifics, innogy SE, Ecosystem Integrity Fund and the Partnership Fund for New York City.

Sapphire Ventures appoints Gordish as marketing VP

Sapphire Ventures has hired Stefanie Gordish as vice president of marketing. Previously, Gordish worked at Marketo where she led communications.

McKesson Ventures hires principal and director

McKesson Ventures has named Carrie Hurwitz Williams as a principal and Irem Mertol as director. Previously, Williams worked at Omada Health where he served as vice president of strategy and business development while Mertol worked at Burd Health.

Engage Therapeutics hauls in $23 mln Series A

Summit, New Jersey-based Engage Therapeutics Inc, a developer of treatments for people who experience uncontrolled epileptic seizures, has secured $23 million in Series A financing. TPG Biotech led the round with participation from Adage Capital Management and Lumira Capital. LifeSci Capital was the lead placement agent.

Legion Technologies attracts $10.5 mln Series A

Menlo Park, California-based Legion Technologies Inc, an intelligent workforce engagement platform, has raised $10.5 million in Series A financing. Norwest Venture Partners led the round with participation from other investors that included First Round Capital, XYZ Ventures and Webb Investment Network. In conjunction with the funding, Sean Jacobsohn, a partner at Norwest, has joined the Legion Technologies' board of directors.